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1) Sugita et al. 2) found and characterized a new neogala series of glycosphingolipids, of which core structure was a b-D-Galp-(1→6)-b-D-Galp-containing a mannose, glucose and phosphocholine residue from the earthworm Pheretima (P.) hilgendorfi. In the previous paper 1e) we reported the synthesis of neogala series glycosphingolipids containing a mannose residue from P. hilgendorfi. In the present study, we attempted the synthesis of the novel neogala series of glycosphingolipids containing the phosphocholine residue. These compounds have a phosphocholine group at the C-6 position of the galactose moiety to form a zwitterionic structure A and B (Fig. 1) . Furthermore Noda and his co-workers also isolated 3) similar compounds and examined the structure-bioactivity relationships about fruiting-inducing effect. 4) As part of our program of oligosaccharide synthesis, the preparation of neogala series containing a phosphocholine group at the C-6 position of the galactose moiety, from P. hilgendorfi, became of interest. Toward that end, the key reaction is a coupling of a phosphocholine group at the C-6 position of the galactose moiety. Concerning that, another novel phosphocholine-containing glycosphingolipids called GGPL-I and GGPL-III were found from the main cell membrane lipid components of Mycoplasma fermentans and these compounds were synthesized by Kobayashi and his coworkers.
5) They used a phosphorodiamidite method at the C-6 position of glucose unit, p-nitrophenyl ( pNP) 6-O-phosphocholine a-D-glucopyranoside. Up to the present, coupling incorporation of phosphocholine was performed as follows: A) phosphorylation with 2-bromoethyl phosphoryl dichloride and trimethylamine ; C) phosphorylation with 2-chloro-2-oxo-1,3,2-dioxaphospholane 7) in place of 2-bromoethyl phosphoryl dichloride. However, for the phosphorylation of carbohydrate hydroxy group, either A) or B) 5b,6b) was used. In the present study, we investigated mono-and disaccharides phosphorylation by means of method C) using 2-chloro-2-oxo-1,3,2-dioxaphospholane and trimethylamine and attempted the synthesis of these novel amphoteric glycosphingolipid analogues containing fatty alkyl residue in place of ceramide. Furthermore, final compounds were examined for their ability to inhibit the histamine release in vitro.
Results and Discussion
Synthesis of Monosaccharide Containing Phosphocholine Octyl 2,3,4-tri-O-benzyl-b -D-galactopyranoside (1) 8) was chosen as an acceptor prepared from octyl b-Dgalactopyranoside. Introduction of a phosphocholine group at the position C-6 of 1 was attempted using 2-chloro-2-oxo-1,3,2-dioxaphospholane, followed by reaction of the resulting cyclic phosphate intermediate with anhydrous trimethylamine at 65°C in a sealed vessel to give 2 in 68% yield for two steps. Compound 2 revealed an [MϩH] ϩ ion peak at m/z 728 in the time of flight mass spectrometer (TOF-MS) spectrum. Removal of the benzyl groups from 2 by catalytic hydrogenolysis over 10% Pd-C gave the target compound 3 (Chart 1).
Synthesis of Disaccharide Containing Phosphocholine The disaccharide derivative 5 was obtained by condensation of 1 with phenyl 1-thio-2,3, (4) in the presence of Niodosuccinimide (NIS) and trifluoromethanesulfonic acid (TfOH). 9) Stereochemical control was achieved by using the solvent effect of nitrile 10) to give the desired b-glycoside 5 in 91% yield and the a-glycoside was not detected. The anomeric hydrogen atom of the nonreducing-end galactose unit appeared as a signal at d 4.22 (d, Jϭ7. Two kinds of amphoteric glycosphingolipid analogues from the earthworm Pheretima hilgendorfi were synthesized as follows: The key reaction is a coupling of a phosphocholine group at the position C-6 of 1 and 6 which was attempted using 2-chloro-2-oxo-1,3,2-dioxaphospholane, followed by reaction of the resulting cyclic phosphate intermediate with anhydrous trimethylamine to give 2 and 7. Subsequent debenzylation afforded target compounds (3, 8) . Their ability to inhibit the histamine release in vitro was examined. Chem. Pharm. Bull. 49(11) 1464 -1467 (2001 Vol. 49, No. 11 Fig. 1 configuration of the newly formed glycosidic bond was also supported by the J C,H value of 159.7 Hz in the 13 C-NMR spectrum. 11) Removal of the tert-butyldimethylsilyl (TBDMS) group from 5 by Bu 4 NF gave the disaccharide intermediate 6 in 86% yield. Coupling of a phosphocholine group with 6 as described for 2 gave the desired compound 7 (91%), and removal of the benzyl groups from 7 by catalytic hydrogenolysis over 10% Pd-C gave the target compound 8 (Chart 2).
Biological Activities The biological activity of compound 3, 8 and phosphocholine free compound 9 were assayed in vitro by histamine release-inhibition test. The method using rat basophilic leukemia cells (RBL-2H3) was reported by Teshima et al. 12) As shown in Fig. 2 , compounds 3 and 8 showed a better activity for histamine release-inhibition from RBL-2H3 cell than compound 9. The IC 50 values were 2.6 mM (3), 2.9 mM (8) and Ͼ10 mM (9). On the other hand, octyl b-D-galactopyranoside could not assay in order to show a potent cytotoxicity.
In summary, we have synthesized for the first time the oligosaccharides including phosphocholine using 2-chloro-2-oxo-1,3,2-dioxaphospholane in good yield and a phosphocholine group seemed to act as a inhibitor to a histamine release.
Experimental
Optical rotations were determined with a JASCO digital polarimeter.
1 Hand 13 C-NMR spectra were recorded on a JNM A 500 FT NMR spectrometer in CDCl 3 with Me 4 Si as the internal standard. Matrix-assisted laser desorption ionization (MALDI-TOF-MS) was recorded on a Perceptive Voyager RP mass spectrometer. TLC was performed on Silica gel 60 F 254 (E. Merck) with detection by quenching of UV fluorescence and by spraying with 10% H 2 SO 4 . Column chromatography was carried out on Silica Gel 60 (E. Merck). Octyl 2,3,4-tri-O-benzyl-b-D-galactopyranoside (1) was prepared by a literature method.
8)

Octyl 2,3,4-Tri-O-benzyl-6-O-phosphocholine-b b-D-galactopyranoside
(2) To a solution of 1 (102 mg, 0.18 mmol) and triethylamine (50 mg, 0.36 mmol) in dry benzene (5 ml) was added 2-chloro-2-oxo-1,3,2-dioxaphospholane (50 ml, 0.54 mmol) at room temperature. After stirring for 3 h at room temperature, the reaction mixture was filtered to remove the precipitated salts. The filtrate and washing were combined and concentrated. This compound was transferred into a sealed vessel as a solution in 10 ml of dry acetonitrile. To the solution was added 100 ml of trimethylamine and the bottle was sealed and then heated in an oil bath at 65°C for 48 h. Resulting mixture was concentrated and the residue was purified by Iatrobeads chromatography, eluting with CHCl 3 -MeOH-H 2 O (8 : 4 : 1) to give the desired compound (2) 
Octyl 6-O-Phosphocholine-b b-D-galactopyranoside (3)
A solution of 2 (81.5 mg, 0.11 mmol) in MeOH (4 ml) containing conc. HCl (0.1 ml) was hydrogenated over 10% Pd-C (57 mg) for 12 h at room temperature, then filtered through Celite and the filter cake was washed with methanol. Combined filtrate and washings were concentrated. Column chromatography (MeOH : H To a solution of 4 (342 mg, 0.52 mmol) and compound 1 (203 mg, 0.36 mmol) in dry C 2 H 5 CN (2 ml) was added powdered MS-AW300 (0.4 g) and the mixture was stirred for 2 h at room temperature, then cooled to Ϫ60°C. NIS (178 mg, 0.79 mmol) and TfOH (1.5 ml, 0.36 mmol) were added to the mixture, which was stirred for 10 min. at Ϫ60°C, then neutralized with Et 3 N. The solids were filtered off and washed with CHCl 3 . The combined filtrate and washings were successively washed with aq. Na 2 S 2 O 3 and water, dried (Na 2 SO 4 ), and concentrated. The residue was chromatographed on silica gel using 15 : 1 benzene-acetone as an eluent to give 5 (365 mg, 91%). To a solution of 6 (105 mg, 0.11 mmol) and triethylamine (21 ml, 0.15 mmol) in dry benzene (5 ml) was added 2-chloro-2-oxo-1,3,2-dioxaphospholane (46 ml, 0.50 mmol) at room temperature. After stirring for 12 h at room temperature, the reaction mixture was filtered to remove the precipitated salts. The filtrate and washings were combined and concentrated. This compound was transferred into a sealed vessel as a solution in 7 ml of dry acetonitrile. To the solution was added 95 ml of trimethylamine. The bottle was sealed and then heated in an oil bath at 65°C for 48 h. Resulting mixture was concentrated, and the residue was purified by Iatrobeads chromatography, eluting with CHCl 3 -MeOH (1 : 1) to give the desired compound (7) 
